HomeCompareIPA vs BTI

IPA vs BTI: Dividend Comparison 2026

IPA yields 123.46% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IPA wins by $9.69M in total portfolio value
10 years
IPA
IPA
● Live price
123.46%
Share price
$1.62
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.73M
Annual income
$3,751,721.48
Full IPA calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — IPA vs BTI

📍 IPA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPABTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPA + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IPA pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPA
Annual income on $10K today (after 15% tax)
$10,493.83/yr
After 10yr DRIP, annual income (after tax)
$3,188,963.26/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, IPA beats the other by $3,186,594.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPA + BTI for your $10,000?

IPA: 50%BTI: 50%
100% BTI50/50100% IPA
Portfolio after 10yr
$4.88M
Annual income
$1,877,254.06/yr
Blended yield
38.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

IPA
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-1.1
Piotroski
4/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPA buys
0
BTI buys
0
No recent congressional trades found for IPA or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPABTI
Forward yield123.46%5.38%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$9.73M$37.7K
Annual income after 10y$3,751,721.48$2,786.64
Total dividends collected$8.87M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: IPA vs BTI ($10,000, DRIP)

YearIPA PortfolioIPA Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$23,046$12,345.68$11,299$598.92+$11.7KIPA
2$51,249$26,590.15$12,794$703.91+$38.5KIPA
3$110,099$55,262.82$14,518$829.07+$95.6KIPA
4$228,762$110,955.31$16,513$978.64+$212.2KIPA
5$460,233$215,458.11$18,827$1,157.84+$441.4KIPA
6$897,560$405,110.78$21,518$1,373.12+$876.0KIPA
7$1,698,762$738,373.02$24,657$1,632.46+$1.67MIPA
8$3,123,730$1,306,054.02$28,329$1,945.74+$3.10MIPA
9$5,586,883$2,244,492.70$32,637$2,325.33+$5.55MIPA
10$9,729,687$3,751,721.48$37,708$2,786.64+$9.69MIPA

IPA vs BTI: Complete Analysis 2026

IPAStock

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Full IPA Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this IPA vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPA vs SCHDIPA vs JEPIIPA vs OIPA vs KOIPA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.